Study on the CHJ01 antitumor activity and mechanism via targeting sphingosine kinase 1 in A549 cells
The SphK1 inhibitor development is of great importance for the treatment of non-small cell lung cancer (NSCLC). In this study, CHJ01 which has been previously shown anti-tumor effects was introduced to investigate the detailed antitumor mechanism both in vitro and in vivo. CHJ01 inhibited the A549 ...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2025-12-01
|
| Series: | Pharmaceutical Science Advances |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2773216925000157 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|